Jeffrey A Zablocki

Title: Jeffrey A. Zablocki: Innovator in Pharmaceutical Compounds

Introduction

Jeffrey A. Zablocki is a notable inventor based in Lafayette, Colorado. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for treating various diseases. His work focuses on innovative solutions that address critical health issues.

Latest Patents

Zablocki holds a patent for "Substituted pyridone compounds and methods of use." This invention encompasses selected novel substituted pyrimidinone and pyridone compounds that are effective for the prophylaxis and treatment of diseases mediated by TNF-α, IL-1β, IL-6, and IL-8, as well as other conditions such as pain and diabetes. The patent includes novel compounds, analogs, prodrugs, and pharmaceutically acceptable salts, along with pharmaceutical compositions and methods for treating inflammation, pain, and diabetes. Additionally, the invention relates to processes for making these compounds and intermediates useful in such processes. Zablocki has 1 patent to his name.

Career Highlights

Jeffrey A. Zablocki is associated with Amgen Inc., a leading biotechnology company known for its innovative therapies. His work at Amgen has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Zablocki has collaborated with esteemed colleagues, including Ulrike D. Spohr and Michael J. Malone. These collaborations have further enhanced the impact of his research and innovations in the field.

Conclusion

Jeffrey A. Zablocki is a distinguished inventor whose work in pharmaceutical compounds has the potential to significantly improve treatment options for various diseases. His contributions reflect a commitment to advancing medical science and enhancing patient care.